Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
WBELX
Price
$9.28
Change
-$0.02 (-0.22%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs WBELX

Header iconFNWFX vs WBELX Comparison
Open Charts FNWFX vs WBELXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
William Blair Emerging Mkts Ldrs I
Price$9.28
Change-$0.02 (-0.22%)
VolumeN/A
CapitalizationN/A
FNWFX vs WBELX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. WBELX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and WBELX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. WBELX (181M). FNWFX pays higher dividends than WBELX: FNWFX (1.56) vs WBELX (0.77). FNWFX was incepted earlier than WBELX: FNWFX (8 years) vs WBELX (17 years). WBELX is a more actively managed with annual turnover of: 44.00 vs. FNWFX (32.00). WBELX has a lower initial minimum investment than FNWFX: WBELX (500000) vs FNWFX (1000000). FNWFX (11.59) and WBELX (11.10) have marching annual gain over last year. FNWFX return over 5 years is better than : 17.23 vs. WBELX (-5.53).
FNWFXWBELXFNWFX / WBELX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years17 years-
Gain YTD7.1475.936120%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B181M33,646%
Annual Yield % from dividends1.560.77202%
Returns for 1 year11.5911.10104%
Returns for 3 years-14.49-28.1551%
Returns for 5 years17.23-5.53-311%
Returns for 10 yearsN/A0.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology